PEREGRINE CAPITAL MANAGEMENT LLC - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 216 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2023. The put-call ratio across all filers is 2.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
PEREGRINE CAPITAL MANAGEMENT LLC ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$7,365,416
-18.8%
146,663
+2.1%
0.22%
-10.9%
Q2 2023$9,074,825
+26.4%
143,589
-10.0%
0.25%
+19.3%
Q1 2023$7,180,584
+127713.9%
159,604
+24.5%
0.21%
+17.6%
Q4 2022$5,618
-99.9%
128,242
+14.2%
0.18%
-26.7%
Q3 2022$7,399,000
+10.4%
112,288
-15.3%
0.24%
+18.8%
Q2 2022$6,699,000
-17.3%
132,621
+4.5%
0.20%
+5.2%
Q1 2022$8,104,000
-38.8%
126,868
+2.6%
0.19%
-27.5%
Q4 2021$13,246,000
+7.2%
123,669
+2.9%
0.26%
+3.5%
Q3 2021$12,355,000
-12.0%
120,169
-24.7%
0.26%
+1.6%
Q2 2021$14,037,000
-4.5%
159,583
+5.6%
0.25%
-7.4%
Q1 2021$14,693,000
-23.9%
151,112
-12.2%
0.27%
-25.9%
Q4 2020$19,312,000
+10.9%
172,198
-8.3%
0.37%
-20.6%
Q3 2020$17,414,000
+31.2%
187,849
+10.4%
0.46%
+22.5%
Q2 2020$13,268,000
+14.3%
170,107
-14.3%
0.38%
-9.4%
Q1 2020$11,606,000198,4670.42%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders